Royalty Pharma Plc (RPRX) — Cash Flow Quality Index
Royalty Pharma Plc (RPRX) has a Cash Flow Quality Index of 2.58x as of March 2026. Operating cash flow of $760.54 Million exceeds net income of $294.69 Million, indicating high earnings quality where cash backs reported profits. Explore Royalty Pharma Plc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Royalty Pharma Plc Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Royalty Pharma Plc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Royalty Pharma Plc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Royalty Pharma Plc (2017–2025)
Year-by-year earnings quality comparison for Royalty Pharma Plc. For live market cap and the full company financial profile, see RPRX stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.88x | $2.49 Billion | $1.32 Billion | ▼ -9.6% |
| 2024 | 2.08x | $2.77 Billion | $1.33 Billion | ▲ +18.4% |
| 2023 | 1.76x | $2.99 Billion | $1.70 Billion | ▼ -81.1% |
| 2022 | 9.32x | $2.14 Billion | $230.06 Million | ▲ +473.3% |
| 2021 | 1.63x | $2.02 Billion | $1.24 Billion | ▲ +36.0% |
| 2020 | 1.20x | $2.03 Billion | $1.70 Billion | ▲ +76.5% |
| 2019 | 0.68x | $1.67 Billion | $2.46 Billion | ▼ -36.5% |
| 2018 | 1.07x | $1.62 Billion | $1.52 Billion | ▲ +1.0% |
| 2017 | 1.06x | $1.42 Billion | $1.34 Billion | — |